COVID-19 Vaccines Show No Link to Increased Mortality, Major French Study Confirms
Paris, France – A thorough analysis of over 60,000 deaths in France spanning May 2021 to July 2022 has found no evidence of excess mortality linked to mRNA COVID-19 vaccines, researchers from the EPI-PHARE project announced today.The study, offering four years of retrospective data, provides further reassurance regarding the safety profile of the vaccines widely deployed during the pandemic.
The research focused on analyzing mortality rates in the weeks following vaccination, a period where any immediate risks would be most apparent. Contrary to concerns raised by vaccine hesitancy, the data revealed approximately 30% lower mortality in the six months post-vaccination. While acknowledging that vaccinated individuals are often more health-conscious, researchers state the conclusion remains clear: there is no indication of short-term danger associated with the mRNA vaccines.
The EPI-PHARE team cautioned that science is an iterative process,adn some data remains incomplete,particularly regarding specific causes of death after 2023. They also noted the potential for health pass fraud, which could underestimate the vaccine’s protective effects.However, the overall assessment is definitive. To date, no increase in mortality has been observed in over 54.2 million people in France who received at least one dose of an mRNA COVID-19 vaccine, according to Ameli data from 2023.
“There is no warning signal, no trace of worrying excess mortality,” the report concludes.
